OppenheimerFunds’s Pacific Biosciences PACB Stock Holding History

OppenheimerFunds’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$208K	Sell	28,706 -343,969	-92%	-$2.49M	﹤0.01%	1700
2018 Q4	$2.76M	Buy	+372,675	New	+$2.36M	﹤0.01%	818
2018 Q1	–	Sell	-12,662	Closed	-$33K	–	1818
2017 Q4	$33K	Buy	+12,662	New	+$44.3K	﹤0.01%	1832

Other funds holding PACB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

OppenheimerFunds's PACB Position: Q1 2019 in Review

OppenheimerFunds reduced its Pacific Biosciences (PACB) stake by 92% in Q1 2019, selling an estimated $2.49M and leaving 28,706 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #1700.

OppenheimerFunds first reported a position in PACB in Q4 2017 and has held it in 3 quarters since. The position peaked at $2.76M in Q4 2018. 160 funds tracked by Wall St. Rank hold PACB as of Q1 2019.

OppenheimerFunds held 28,706 shares of Pacific Biosciences worth $208K as of Q1 2019.
OppenheimerFunds sold 343,969 Pacific Biosciences shares in Q1 2019, an estimated $2.49M.
Pacific Biosciences made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1700 holding.
OppenheimerFunds first reported a position in Pacific Biosciences in Q4 2017 and has held it in 3 quarters since.
OppenheimerFunds's Pacific Biosciences position peaked at $2.76M in Q4 2018.
160 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.